Br. J. Haematol..2020 Jun;doi: 10.1111/bjh.16804.Epub 2020-06-09.
再発・難治性急性骨髄性白血病患者を対象としたselinexorとcytarabineおよびidarubicinの第Ⅱ相試験
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
- Walter Fiedler
- Joerg Chromik
- Stefanie Amberg
- Maxim Kebenko
- Felicitas Thol
- Vera Schlipfenbacher
- Anne Christine Wilke
- Franziska Modemann
- Melanie Janning
- Hubert Serve
- Arnold Ganser
- Carsten Bokemeyer
- Susann Theile
- Ute Deppermann
- Anne L Kranich
- Michael Heuser
PMID: 32515072 DOI: 10.1111/bjh.16804.
抄録
抄録はありません
